Navigation Links
Premier Research Strengthens their Medical Affairs and Strategic Consulting Group with New Appointments
Date:9/9/2009

PHILADELPHIA, Sept. 9 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointments of two physicians, Dr. Patricia Taylor Molloy and Dr. Michael H. Skinner, to their Medical Affairs and Strategic Consulting Group. The addition of these clinicians will significantly enhance Premier Research's expertise, particularly in the areas of neurology, oncology, pediatrics, and analgesia.

Patricia Molloy, MD has been appointed to the position of Vice President, Global Medical Affairs and Strategic Consulting. In this role, she will be responsible for global oversight of Medical Affairs and Strategic Consulting. Dr. Molloy brings more than 18 years of research experience with extensive late stage clinical development expertise in oncology, neurology and pediatrics. Dr. Molloy was most recently Senior Medical Director, Oncology and Neurology at Cephalon, and has held previous positions in oncology and neurology research at Kyowa Pharmaceuticals, ImClone Systems, and Allergan. She is a board certified neurologist with a fellowship in neuro-oncology.

Michael H. Skinner, MD, PharmD has been appointed as an Executive Director, Medical Affairs and Strategic Consulting. Dr. Skinner will provide consulting, strategic development and medical monitoring services in the areas of internal medicine and analgesia. Dr. Skinner brings to Premier Research more than 12 years of pharmaceutical experience. His prior experience includes senior level positions at a number of pharmaceutical and biotechnology companies, most recently as the Senior Medical Director at Somaxon Pharmaceuticals and Vice President Clinical Development at Allergan, Inc. Prior to that, Dr. Skinner has held positions at Neurocrine Biosciences and Eli Lilly & Co. He is a board certified in internal medicine and clinical pharmacology with fellowships clinical pharmacology and substance abuse.

"Each appointment brings medical expertise, strong clinical knowledge, leadership, and a wealth of experience in key areas that are of importance for our clients and will provide an added level of therapeutic insight to Premier Research's service offerings," said James Ottinger, Vice President, Global Consulting and Compliance. "They are welcome additions to our team."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Dental Association Offers Premier Accounts Receivable Management Services from TekCollect via TDA Perks Program
2. Premier Inc. Awards Dynamic Computer Corporation With a Group Purchasing Agreement to Provide RFID Asset Tracking and Management Solutions for Its Member Network
3. New Shocking Documentary on Lyme Disease 'Under the Eightball' to Premiere at Michael Moore's State Theater in Traverse City, Michigan
4. Hemostatic HemCon Dressings Selected by the Premier Healthcare Alliance for Hemostasis Products Contract
5. Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles
6. Premier Visiting Nurse Selects Cardiocom Telehealth Technology
7. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
8. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
9. RF Technologies Achieves Premier Certification From Cisco in United States
10. MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation
11. "Aprima Medical Software, Inc.," Unveiled by iMedica; Premier EHR / PM Company Adopts New Name
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PITTSBURGH, PA (PRWEB) , ... December 09, 2016 , ... ... treatments," said an inventor from Winchester, Va. "I thought that if the nebulizer had ... their treatments rather than fearing them." , He developed the patent-pending NEBY to avoid ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Medical Center has been recognized for adherence to the highest standards of ... medical accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... -- Research and Markets has announced the addition of ... Type, Application, Usability - Forecast to 2025" report to their ... , , ... to grow at a CAGR of around 3.2% from 2015 to ... include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in ...
(Date:12/8/2016)...   TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...
Breaking Medicine Technology: